Abstract Background Precision medicine (PM) adoption is accelerating across Asia, but implementation remains uneven due to differences in financing, infrastructure, governance, and health-system readiness. Objectives To examine how six Asian countries (Singapore, South Korea, China, Malaysia, Thailand, and Indonesia) a...
A. L. T. Peh, Y. Teerawattananon, Jeanette Yuen et al.· Health affairs scholar· 0 citations
Moderate to high certainty evidence supports discontinuation of drugs for adults with overweight or obesity because of adverse events to be highest with orforglipron, naltrexone-bupropion, liraglutide, phentermine-topiramate, CagriSema, and oral semaglutide.
Kai-Lei Nong, Qingyang Shi, Xinran Xie et al.· British medical journal· 5 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.